Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Ross

Showing results (1-10 of 345) with videos related to

Pageof 35
Sort By:
The Journal of Infectious Diseases|February 5, 2019
Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin ProteinsTed M Ross
Clinics in Laboratory Medicine|June 2, 2010
Dengue virusTed M Ross
Human Vaccines & Immunotherapeutics|November 11, 2015
Portrait of Dr. Ted M. RossTed M Ross
NPJ Vaccines|December 22, 2017
Commentary on 'Dissecting the hemagglutinin head and stalk specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination'Ted M Ross
Plos One|March 18, 2021
Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particlesHyesun Jang, Ted M Ross
Vaccines|November 26, 2024
Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune ResponsesEngin Berber, Ted M Ross
Emerging Microbes & Infections|October 11, 2018
Dengue virus and the host innate immune responseNaoko Uno, Ted M Ross
Veterinary Microbiology|October 31, 2020
Dried SARS-CoV-2 virus maintains infectivity to Vero E6 cells for up to 48 hHyesun Jang, Ted M Ross
Expert Review of Vaccines|May 3, 2022
Next generation live-attenuated influenza vaccine platformsSubhan Ullah, Ted M Ross
Expert Review of Vaccines|October 3, 2019
Preexisting influenza specific immunity and vaccine effectivenessHyesun Jang, Ted M Ross
Pageof 35

Showing results (1-10 of 345) with videos related to

Sort By:
Pageof 35
The Journal of Infectious Diseases|February 5, 2019
Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin ProteinsTed M Ross
Clinics in Laboratory Medicine|June 2, 2010
Dengue virusTed M Ross
Human Vaccines & Immunotherapeutics|November 11, 2015
Portrait of Dr. Ted M. RossTed M Ross
NPJ Vaccines|December 22, 2017
Commentary on 'Dissecting the hemagglutinin head and stalk specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination'Ted M Ross
Plos One|March 18, 2021
Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particlesHyesun Jang, Ted M Ross
Vaccines|November 26, 2024
Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune ResponsesEngin Berber, Ted M Ross
Emerging Microbes & Infections|October 11, 2018
Dengue virus and the host innate immune responseNaoko Uno, Ted M Ross
Veterinary Microbiology|October 31, 2020
Dried SARS-CoV-2 virus maintains infectivity to Vero E6 cells for up to 48 hHyesun Jang, Ted M Ross
Expert Review of Vaccines|May 3, 2022
Next generation live-attenuated influenza vaccine platformsSubhan Ullah, Ted M Ross
Expert Review of Vaccines|October 3, 2019
Preexisting influenza specific immunity and vaccine effectivenessHyesun Jang, Ted M Ross
Pageof 35